News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
17,978 Results
Type
Article (583)
Company Profile (3)
Press Release (17392)
Section
Business (10207)
Career Advice (8)
Deals (1582)
Drug Delivery (1)
Drug Development (1307)
Employer Resources (2)
FDA (215)
Job Trends (567)
News (12428)
Policy (437)
Tag
Academia (41)
Allergies (6)
Alliances (603)
ALS (3)
Alzheimer's disease (31)
Antibody-drug conjugate (ADC) (7)
Approvals (218)
Artificial intelligence (4)
Autoimmune disease (1)
Automation (1)
Bankruptcy (6)
Best Places to Work (514)
Biosimilars (2)
Biotechnology (1)
Bladder cancer (7)
Breast cancer (9)
Cancer (88)
Cardiovascular disease (8)
Career advice (9)
CAR-T (4)
Cell therapy (10)
Cervical cancer (1)
Clinical research (1176)
Collaboration (20)
Compensation (11)
Complete response letters (1)
COVID-19 (47)
CRISPR (1)
C-suite (8)
Cystic fibrosis (3)
Data (102)
Depression (4)
Diabetes (7)
Diagnostics (207)
Digital health (3)
Diversity, equity & inclusion (1)
Drug discovery (3)
Drug pricing (1)
Duchenne muscular dystrophy (12)
Earnings (9858)
Editorial (2)
Employer resources (2)
Events (1024)
Executive appointments (12)
FDA (352)
Frontotemporal dementia (1)
Funding (34)
Gene editing (3)
Generative AI (1)
Gene therapy (9)
GLP-1 (22)
Government (44)
Guidances (103)
Healthcare (617)
HIV (1)
IgA nephropathy (2)
Immunology and inflammation (4)
Immuno-oncology (1)
Indications (3)
Infectious disease (56)
Inflammatory bowel disease (1)
Inflation Reduction Act (1)
Influenza (2)
Intellectual property (6)
Interviews (1)
IPO (1198)
IRA (1)
Job creations (97)
Job search strategy (6)
Labor market (1)
Layoffs (11)
Legal (68)
Liver cancer (4)
Lung cancer (11)
Lymphoma (7)
Manufacturing (9)
MASH (2)
Medical device (597)
Medtech (599)
Mergers & acquisitions (409)
Metabolic disorders (21)
Multiple sclerosis (3)
NASH (1)
Neurodegenerative disease (5)
Neuropsychiatric disorders (3)
Neuroscience (51)
NextGen: Class of 2025 (160)
Non-profit (67)
Now hiring (1)
Obesity (13)
Opinion (7)
Ovarian cancer (2)
Pancreatic cancer (4)
Parkinson's disease (5)
Patents (8)
Patient recruitment (1)
Peanut (4)
People (461)
Pharmacy benefit managers (1)
Phase I (258)
Phase II (482)
Phase III (531)
Pipeline (327)
Policy (2)
Postmarket research (45)
Preclinical (90)
Prostate cancer (4)
Radiopharmaceuticals (9)
Rare diseases (13)
Real estate (83)
Recruiting (1)
Regulatory (384)
Reports (1)
Research institute (40)
Resumes & cover letters (2)
Rett syndrome (1)
RNA editing (1)
RSV (4)
Schizophrenia (1)
Series A (6)
Series B (7)
Service/supplier (1)
Sickle cell disease (2)
Startups (54)
Stomach cancer (1)
Vaccines (28)
Venture capital (1)
Weight loss (9)
Women's health (2)
Worklife (1)
Date
Today (2)
Last 7 days (15)
Last 30 days (50)
Last 365 days (1338)
2025 (949)
2024 (1527)
2023 (1743)
2022 (1775)
2021 (1862)
2020 (1649)
2019 (1204)
2018 (1005)
2017 (845)
2016 (511)
2015 (706)
2014 (472)
2013 (317)
2012 (346)
2011 (385)
2010 (411)
Location
Africa (6)
Alabama (1)
Arizona (8)
Asia (949)
Australia (69)
California (386)
Canada (95)
China (23)
Colorado (20)
Connecticut (17)
Delaware (16)
Europe (2472)
Florida (46)
Georgia (20)
Illinois (30)
India (1)
Indiana (15)
Japan (6)
Kansas (3)
Kentucky (2)
Louisiana (5)
Maine (27)
Maryland (55)
Massachusetts (247)
Michigan (9)
Minnesota (19)
Missouri (3)
Montana (1)
Nevada (1)
New Hampshire (8)
New Jersey (105)
New York (155)
North Carolina (56)
Northern California (191)
Ohio (5)
Pennsylvania (98)
South America (25)
South Carolina (1)
Southern California (166)
Tennessee (9)
Texas (43)
United States (1401)
Utah (7)
Virginia (2)
Washington D.C. (2)
Washington State (19)
Wisconsin (2)
17,978 Results for "175".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Amylyx Pharmaceuticals Announces Pricing of $175 Million Underwritten Public Offering of Common Stock
September 10, 2025
·
4 min read
Press Releases
Assembly Biosciences Announces Pricing of $175 Million in Equity Financings
August 11, 2025
·
6 min read
Press Releases
Longeveron Announces Up To $17.5 Million Public Offering
August 11, 2025
·
7 min read
Press Releases
Longeveron Announces Closing Of Up To $17.5 Million Public Offering
August 12, 2025
·
7 min read
Press Releases
SAB BIO Announces Oversubscribed $175 Million Private Placement
July 22, 2025
·
6 min read
Press Releases
Vor Bio Announces $175 Million Private Placement
June 26, 2025
·
3 min read
Press Releases
Genomics Market Surges with PCR and AI Technologies Projected to Reach USD 175.18 Billion by 2034
July 29, 2025
·
1 min read
Press Releases
LSL PHARMA GROUP SECURES $17.5 MILLION FROM DESJARDINS AND BDC
June 27, 2025
·
4 min read
Press Releases
Xilio Therapeutics Announces Initiation of Phase 2 Trial for Efarindodekin Alfa (XTX301), a Tumor-Activated IL-12, and Achievement of $17.5 Million Development Milestone Under Exclusive License Agreement with Gilead
September 10, 2025
·
9 min read
GLP-1
Prescription Drug Sales Will Hit $1.75T By 2030 Thanks to GLP-1s: Evaluate
Eli Lilly’s tirzepatide is expected to be worth $62 billion annually by 2030, according to Evaluate. That valuation would be three times larger than what AbbVie’s blockbuster Humira ever achieved.
June 25, 2025
·
3 min read
·
Annalee Armstrong
1 of 1,798
Next
